Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA

28 Jan 2023

Abstract excerpt

Hepatocellular carcinoma (HCC) accounts for 90% of primary hepatic malignancies and is one of the major causes of cancer-related death. Over the last 15 years, the molecular landscape of HCC has been deciphered, with the identification of the main driver genes of liver carcinogenesis that belong to six major biological pathways, such as telomere maintenance, Wnt/b-catenin, P53/cell cycle regulation, oxidative...

Topics

Join the communities discussing this publication.

Cancer Genomics and Diagnostics
Hepatocellular Carcinoma Treatment and Prognosis
Renal cell carcinoma treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36765775
DOI: 10.3390/cancers15030817

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNAPMID 36765775Read ↗

Circulating tumor DNA and its role in detection, prognosis and therapeutics of hepatocellular carcinomaSemantic proximity Read ↗

Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.Semantic proximity Read ↗

Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy OutcomesSemantic proximity Read ↗

Biomarkers for diagnosis and therapeutic options in hepatocellular carcinomaSemantic proximity Read ↗

Circulating tumor DNA mutation analysis: advances in its application for early diagnosis of hepatocellular carcinoma and therapeutic efficacy monitoring.Semantic proximity Read ↗

Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular CarcinomaSemantic proximity Read ↗

Hepatocellular carcinoma: old friends and new tricksSemantic proximity Read ↗

Circulating Tumor DNA and Hepatocellular CarcinomaSemantic proximity Read ↗

The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy.Semantic proximity Read ↗

Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.Semantic proximity Read ↗

Prospects and challenges of circulating tumor DNA in precision medicine of hepatocellular carcinoma.Semantic proximity Read ↗

Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision MedicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.